Genetic screening Flashcards
genetic screening is a
population based approach for identifying individuals with increased susceptibility to or risk for a genetic disease in themselves and their offspring.
newborn screening purpose
screening of all babies just after birth.
it identifies genetic diseases that can be treated early in life.
It is performed by state public health deparments and commercial laboratories.
general criteria for newborn screening
treatment is available
early initiation of treatment before symptoms become manifest, reduces or prevents severe illness
routine observation of newborn will not reveal the disorder.
condition is frequent and severe enough to justify screening.
follow up and counseling are available.
prototype for newborn screening is
phenylketouria (PKU) screening
today newborn screening is done by
tandem mass spectrometry (MSMS)
federal government recommends that every newborn screen program in the US include a uniform screening panel of
31 primary and 26 secondary conditions.
this panel is the recommended uniform screening panel.
carrier screening is used to
identify individuals who are carriers for recessive disease in specific ethnic populations.
It is also used to identify couples in which both individuals are carriers for the same genetic disease.
prototype for carrier screening: tay sachs disease
first done with enzyme assay
now performed with DNA and/or enzyme
tay sachs disease symptoms
progressive mental and motor degeneration
macular degeneration
paralysis
uncontrollable seizures
tay sachs disease carrier frequency
ashkenazi Jewish 1:25
french Canadian 1:25
maternal serum screening is done on woman ages
35 and older
maternal serum screens for
alpha fetoprotein (detects neural tube defects and chromosomal abnormalities)
quad screening (four sserum markers increase detection rate of NTD and chromsome abnormalities)
alpha fetoprotein (AFP)
a fetal protein which is produced initially by the yolk sac and then the fetal liver.
it is elevated in fetuses with neural tube defects
it is decreased in fetuses with chromosome defects.
alpha fetoprotein (AFP) is elevated in maternal serum because AFP
diffuses across the placenta.
accuracy of screening for chromosome abnormalities is improved by measuring maternal serum levels of
unconjugated estriol
human chorionic gonadotropin
inhibin